Erica L. Mendelsohn, RPAC

Erica Mendelsohn practices at Arnot Ogden Medical Center in Elmira, New York, part of Centralus Health.

Erica Mendelsohn's NPI, 1164448411, was assigned on July 13, 2006. Erica Mendelsohn holds New York license 006388.

Erica Mendelsohn's primary practice is Arnot Ogden Medical Center, at 600 Roe Avenue, Elmira, NY 14905 in Chemung County. The practice phone is (607) 737-4100.

Erica Mendelsohn's primary practice is Arnot Ogden Medical Center in Elmira, New York, part of Centralus Health. The medical group on file is Arnot Ogden Medical Center. Erica Mendelsohn's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Erica Mendelsohn practices. Vendor and product names are available with a free account.

Physician assistant is Erica Mendelsohn's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Erica Mendelsohn is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Erica Mendelsohn is licensed in New York.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, encephalopathy, epilepsy, essential tremor, head injury, insomnia and intellectual and developmental disabilities among the conditions Erica Mendelsohn treats.

CMS data shows 284 Medicare services from Erica Mendelsohn across 3 procedure codes in 2024, all of them office visits, for 206 Medicare patients. Medicare paid $14,752 for them. Every service was in an office.

CMS counts 206 Medicare patients who saw Erica Mendelsohn in 2024. The largest group is 65 to 74, with 74 patients. 71% of them have high cholesterol, and 66% have high blood pressure. 44% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Erica Mendelsohn's median patient age at 57, with 68% women.

In 2024, Erica Mendelsohn wrote 3,286 Medicare Part D claims for 406 patients. 85% of them were for generic drugs. CMS names the drug for 3,029 of them, across 62 drugs with 11 or more claims each, at $466,983 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Erica Mendelsohn for performance year 2024, reported as part of a group. Erica Mendelsohn accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Erica Mendelsohn as offering telehealth.

CMS Open Payments shows 22 general payments to Erica Mendelsohn from 8 drug and device companies in 2025. Food and beverage make up the largest share, 55% of the total. LivaNova USA, Inc. paid the most, $372.